Skip to main content
HeartCited

Selenium Coronary Artery Disease (CAD)

C エビデンス 小規模研究からのエビデンスは限られていますが、いくつかの肯定的なシグナルがあります。

SELECT trial was negative as monotherapy. KiSel-10 was positive in combination with CoQ10. U-shaped dose response — research suggests benefit only in deficient populations (serum <100 mcg/L).

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dselenium\u0026condition\u003Dcoronary\u002Dartery\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

SELECT trial was negative as monotherapy. KiSel-10 was positive in combination with CoQ10. U-shaped dose response — research suggests benefit only in deficient populations (serum <100 mcg/L).

Key Study Findings

Controlled Clinical Trial
Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / …
Dose: None vs: None Outcome: antioxidant status 効果: None p=0.001

対象集団: patients with depression

Review
Role of mercury toxicity in hypertension, cardiovascular disease, and stroke.
Dose: None vs: None Outcome: blood pressure 効果: None None

対象集団: hypertension patients

Key Statistics

5

研究数

10000

参加者数

Mixed

C

グレード

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
55 mcg/day
cardiovascularantioxidant:
100-200 mcg/day

上限量: 400 mcg/day (risk of selenosis above this level)

研究で検討された用量

用量 期間 効果 N
None -- Neutral --
None -- Positive --

推奨摂取タイミング: With meals

Safety & Side Effects

報告されている副作用

  • Selenosis at high doses (garlic breath odor, hair/nail loss, nausea)
  • GI discomfort at moderate-high doses
  • Potential increased type 2 diabetes risk at high supplemental doses

既知の相互作用

  • Cisplatin and other chemotherapy drugs (may affect efficacy)
  • Statins (may enhance antioxidant effects)
  • CoQ10 (synergistic cardiovascular benefit — KiSel-10 combination)

耐容上限摂取量: 400 mcg/day (risk of selenosis above this level)

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Selenium help with Coronary Artery Disease (CAD)?
Based on 5 studies with 10,000 participants, there is limited but promising evidence that Selenium may support Coronary Artery Disease (CAD) management. Our evidence grade is C (Some Evidence).
How much Selenium should I take for Coronary Artery Disease (CAD)?
Studies have used various dosages. A commonly studied range is 55 mcg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Selenium?
Reported side effects may include Selenosis at high doses (garlic breath odor, hair/nail loss, nausea), GI discomfort at moderate-high doses, Potential increased type 2 diabetes risk at high supplemental doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Selenium and Coronary Artery Disease (CAD)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 10,000 total participants. The overall direction of effect is mixed.

に関する他の成分: Coronary Artery Disease (CAD)

Selenium 他の症状・状態について

References

  1. [1] Mark C Houston. J Clin Hypertens (Greenwich). 2011. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. doi:10.1111/j.1751-7176.2011.00489.x PubMed
  2. [2] Michael Maes et al.. Neuro Endocrinol Lett. 2011. Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway … PubMed

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。